Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing's Syndrome

Ann Surg Oncol. 2015 Dec;22 Suppl 3(Suppl 3):S699-706. doi: 10.1245/s10434-015-4605-1. Epub 2015 May 13.

Abstract

Background: Laparoscopic bilateral adrenalectomy (LBA) is recommended for patients with bilateral adrenal disease and occult or unresectable ectopic Cushing's syndrome (CS). There are limited data on long-term outcomes after LBA, partly due to the lack of disease-specific tools for the measurement of impact on patients' health and quality of life.

Methods: We used a disease-specific questionnaire covering all major clinicopathologic characteristics of CS. We compared the outcome from LBA to a control group of 60 patients who had thyroidectomy (matched for age, gender, and time of surgery, 2:1 control-to-CS).

Results: Twenty-eight patients (20 women and 8 men) underwent LBA for CS. Of them, 24 patients (86 %) provided responses to our questionnaire. Ninety-two percent of patients' responses indicated a significant improvement of general Cushing's physical features with complete resolution reported in 59 % of responses. Significant improvement of associated biochemical abnormalities and comorbidities was reported in 83 % of patients' responses including complete reversal in 58 %. Significant improvement in emotional-behavioral symptoms was reported in 84 % of patients' responses with complete recovery in 53 %. All patients expressed satisfaction with LBA and significant improvement in their general health and self-reported quality of life. All of the improvements after LBA were statistically significant compared with the control group.

Conclusions: Our disease-specific questionnaire enables a clearer understanding of the association between the clinical, metabolic, and emotional-behavioral features of CS, its treatment with LBA, and long-term impact on patient-reported quality of life. This disease-specific questionnaire may be useful for future studies in patients with CS.

Trial registration: ClinicalTrials.gov NCT00005927 NCT01005654 NCT02001051.

Publication types

  • Comparative Study

MeSH terms

  • Adrenalectomy / adverse effects*
  • Adult
  • Case-Control Studies
  • Cohort Studies
  • Cushing Syndrome / pathology
  • Cushing Syndrome / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopy / adverse effects*
  • Male
  • Neoplasm Staging
  • Pilot Projects
  • Postoperative Complications*
  • Prognosis
  • Quality of Life*
  • Surveys and Questionnaires
  • Time Factors

Associated data

  • ClinicalTrials.gov/NCT00005927
  • ClinicalTrials.gov/NCT01005654
  • ClinicalTrials.gov/NCT02001051